NCT03035591View on ClinicalTrials.gov

ODM-207 in Patients With Advance Solid Tumours

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 22, 2016

Primary Completion Date

May 10, 2019

Study Completion Date

May 10, 2019

Conditions
Solid Tumors
Interventions
DRUG

ODM-207

Trial Locations (1)

00029

Helsinki University Central Hospital, Department of Oncology, Helsinki

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT03035591 - ODM-207 in Patients With Advance Solid Tumours | Biotech Hunter | Biotech Hunter